DagbyRM, Corey-KreylingMD. Structural aspects of the contractile machinery of smooth muscle. "Is the organization of contractible elements compatible with a sliding filament mechanism?" In: StephensNL, editor. Smooth muscle contraction. New York: Marcel Dekker, 1984:47–74.
4.
PeachMJ, SingerHA, IzzoNJ, LeobAL. Role of calcium in endothelium-dependent relaxation of arterial smooth muscle. Am J Cardiol1987;59:35A–43A.
5.
WeinheimerG, OsswaldH.Inhibition of endothelium-dependent smooth muscle relaxation by calmodulin antagonists. Arch Pharmacol1986;332:391–397.
6.
CutfieldGR. The systemic and pulmonary circulations. In: TinkerJ, ZapolW, editors. Care of the critically ill patient, 2nd ed. London: Springer-Verlag, 1992:24–38.
7.
GordonAM. Contraction in smooth muscle and non-muscle cells. In: PattonHD, FuchsAF, HilleB, ScherAM, SteinerR, editors. Textbook of physiology: excitable cells and neurophysiology. London: WB Saunders, 1989:214–229.
8.
NonomuraY, EbashiS.Calcium regulatory mechanism in vertebrate smooth muscle. Biomed Res1980;1:1–14.
9.
CookR.The mechanism of muscle contraction. CRC Crit Rev Biochem1986;21:53–118.
10.
GoldmanYE, BrennerB.Special topic: molecular mechanism of muscle contraction. Annu Rev Physiol1987;49:629–636.
11.
GabellaG.Structural apparatus for force transmission in smooth muscles. Physiol Rev1984;64:455–477.
12.
Miller-HanceWC, KammKE, StullJJ. Role of calcium and myosin phosphorylation in arterial smooth muscle contraction. In: AokiK, FrohlichED, editors. Calcium in essential hypertension. London: Academic Press, 1989:133–168.
13.
AlbertsB, BrayD, LewisJ, RaffM, RobertsK, WatsonJD, editors. Molecular biology of the cell, 2nd ed. New York: Garland, 1989:64–65.
14.
HessB, MarkusM.Order and chaos in biochemistry. Trends Biochem Sci1987;12:45–48.
KammKE, StullJT. The function of myosin and myosin light chain kinase: phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol1985;25:593–620.
17.
CassidyP, HoarPE, KerrickWGL. Irreversible thiophosphorylation and activation of tension in functionally skinned rabbit ileum strips by [35S] ATPS. J Biol Chem1979;254:11148–11153.
18.
MurphyRA, AksoyMO, DillonPF, GerthofferWT, KammKE. The role of myosin light chain phosphorylation in regulation of the cross-bridge cycle. Fed Proc1983;42:51–56.
19.
AnderssonR, NilssonK, WikbergJ, JohanssonS, Mohme-LundholmE, LundholmL.Cyclic nucleotides and the contraction of smooth muscle. Adv Cyclic Nucl Res1975;5:491–518.
20.
DiamondJ.Role of cyclic nucleotides in control of smooth muscle contraction. Adv Cyclic Nucl Res1978;9:327–340.
21.
BohmeE, GrafH, SchultzG.Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets. Adv Cyclic Nucl Res1978;9:131–143.
22.
DiamondJ.Lack of correlation between cyclic GMP elevation and relaxation of nonvascular smooth muscle by nitroglycerin, nitroprusside, hydroxylamine and sodium azide. J Pharmacol Exp Ther1983;225:422–426.
23.
GruetterCA, BarryBK, McNamaraDB, GruetlerDY, KadowitzPJ, IgnarroLJ. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and carinogenic nitrosoamine. J Cyclic Nucl Res1979;5:211–224.
24.
CollinsP, GriffithTM, HendersonAH, LewisMJ. Endothelium-derived relaxing factor alters calcium fluxes in rabbit aorta: a cyclic guanosine monophosphate-mediated effect. J Physiol1986;381:427–437.
25.
RapoportRM. Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidyl-inositol hydrolysis in rat aorta. Circ Res1986;58:407–410.
26.
BulbringE, BradingAF, JonesAW, TomitaT.Smooth muscle: an assessment of current knowledge. Austin: University of Texas Press, 1981.
27.
GruetterCA, BarryBK, McNamaraDB, KadowitzPJ, IgnarroLJ. Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N'-nitro-sonornicotine and nitric oxide. J Pharmacol Exp Ther1980;214:9–15.
28.
GruetterCA, GruetterDY, LyonJE, KadowitzPJ, IgnarroLJ. Relationship between cyclic GMP formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther1981;219:181–186.
29.
IgnarroLJ, LipptonHL, EdwardsJC, BaricosWFF, HymanAL, . Mechanism of vascular smooth muscle by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther1981;218:739–749.
30.
IgnarroLJ, GruetterCA. Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols. Biochim Biophys Acta1980;631:221–231.
31.
IgnarroLJ, KadowitzPJ. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol1985;25:171–191.
MoncadaS, GryglewskiRJ, BuntingS, VaneJR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature1976;263:663–665.
34.
FurchgottRF, ZawadzkiJV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature1980;288:373–376.
35.
YanagisawaM, KuriharaH, KimuraS, TomobeY, KobayashiM, MitsuiY, . A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature1988;332:411–415.
36.
Dinh-XuanAT, HigenbottamTW. Non-prostanoid endothelium derived vasoactive factors. J Int Med Res1989;17:305–315.
37.
GriffithTM, EdwardDH, LewisMJ, NewbyAC, HendersonAH. The nature of endothelium-derived vascular relaxant factor. Nature1984;308:645–647.
38.
IgnarroLJ, BugaGM, WoodKS, ByrnsRE, ChaudhuriG.Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA1987;84:9265–9269.
39.
PalmerRMJ, FerrigeAG, MoncadaA.Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature1987;327:524–526.
40.
CocksTM, AngusJA, CampbellJH, CampbellGR. Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. J Cell Physiol1985;123:310–320.
41.
FurchgottRF. The role of the endothelium in the response of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol1984;24:175–197.
42.
FurchgottRF. Studies on the relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable inhibitory factor from bovine retractor penis factor is inorganic nitric oxide and endothelium-derived relaxing factor is nitric oxide. In: VanhoutlePM, editor. Vasodilatation, vascular smooth muscle, peptides, autonomic nerves and endothelium. New York: Raven Press, 1988:401–404.
43.
CremonaG, Dinh-XuanAT, HigenbottamTW. Review: endothelium-derived relaxing factor and the pulmonary circulation. Lung1991;169:185–202.
44.
VaneJR, AngaardEE, BottingRM. Regulatory functions of the vascular endothelium. N Engl J Med1990;323:27–36.
45.
WestJB. Respiratory physiology, 4th ed. Baltimore: Williams and Wilkins, 1990:43–44.
46.
HarperRW. A guide to respiratory care: Phys. 1 Clin. Applic. Philadelphia: JB Lippincott Co, 1981.
47.
WestJB. Pulmonary pathophysiology, 4th ed. Baltimore: Williams & Wilkins, 1990:29.
48.
FishmanAP. Hypoxia on the pulmonary circulation: how and where it acts. Circ Res1976;38:221–231.
49.
PhilipsJBIII. Prostaglandin and related compounds in the perinatal pulmonary circulation. Pediatr Pharmacol1983;4:129–142.
50.
EdwardsJC, IgnarroLJ, HymanAL, KadowitzPJ. Relaxation of intra-pulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP. J Pharmacol Exp Ther1984;228:33–42.
51.
HolzmannS.Endothelium induced relaxation by acetylcholine associated with large rises in cyclic GMP in coronary arterial strips. J Cyclic Nucl Res1982;8:409–419.
52.
MelotC, NaeijeR, MolsP, VandenbosscheJL, DenolinH.Effects of nifedipine on ventilation/perfusion matching in primary pulmonary hypertension. Chest1983;83:203–207.
53.
Abu-OsbaYK, ManasraK, GalalO, RejjalA.Treatment of pulmonary hypertension of newborn (PPHN) with magnesium (abstract). Pediatr Res1990;27(2):294A.
54.
GottliebSS, WoodLDH, HansenDD, LongR.The effect of nitro-prusside on pulmonary edema, oxygen exchange, and blood flow in hydrochloric acid aspiration. Anesthesiology1987;67:203–210.
55.
RadermacherP, HuetY, PluskwaF, HerigaultR, MalH, TeisseireB, . Comparison of ketanserin and sodium nitroprusside in patients with severe ARDS. Anesthesiology1988;68:152–157.
56.
RadermacherP, SantakB, BeckerH, FalkeKJ. Prostaglandin El and nitroglycerin reduce pulmonary capillary pressure but worsen ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology1989;70:601–606.
DavidsonD, EldemerdashA.Endothelium derived relaxing factor: presence in pulmonary and systemic arteries of the newborn guinea pig. Pediatr Res1990;27(2):128–132.
59.
AbnanSH, CharfieldBA, HallSL, McMurtryIF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol1990;259:H1921–1927.
60.
FinemanJR, HeymannMA, SoiferSJ. N omega-nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. Am J Physiol1991;260:H1299–1306.
61.
ShaulPW, FarrarMA, ZellersTM. Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries. Am J Physiol1992;262:H355–364.
62.
TiktinskyMH, CummingsJJ, MorinFCIII. Acetylcholine increased pulmonary blood flow in intact fetuses via endothelium-dependent vasodilation. Am J Physiol1992;262:H406–410.
63.
IgnarroLJ, AdamsJB, HorwitzPM, WoodKS. Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms. J Biol Chem1986;262(11):4997–5002.
64.
PollockJS, ForstermannU, MitchellJA, . Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA1991;88:10480–10484.
65.
Dinh-XuanAT, HigenbottamJ, Pepke-ZabaJ, ButtAY, CremonaG.Evidence for dysfunction of the enzyme nitric oxide synthase in the mechanisms of impaired pulmonary endothelium-dependent relaxation in chronic hypoxic lung disease (abstract). Am Rev Respir Dis1992;145(4):A207.
66.
MoncadaS, PalmerRMJ, HiggsEA. Biosynthesis of nitric oxide from L-arginine: a pathway for the regulation of cell function and communication. Biochem Pharmacol1988;38:1709–1715.
EddahibiS, CarvilleC, RaffestinB, AdnotS.In vivo administration of L-arginine restores endothelium dependent relaxant activity in the pulmonary circulation of chronically hypoxic rats (abstract). Am Rev Respir Dis1992;145(4):A208.
69.
SchmidtHH, NauH, WittfohtW, GerlachJ, PrescherKE, KleinMM, . Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol1988;54(2):213–216.
70.
GriffithOW, ParkKH, LeviR, GrossSS. The role of plasma arginine in nitric oxide synthesis: studies with arginase-treated rats. Second International Meeting on the Biology of Nitric Oxide. London, October, 1991.
71.
PalmerRMJ, MoncadaA.A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun1989;158:348–352.
72.
IgnarroLJ, GruetterCA, HymanAL, KadowitzPJ. Molecular mechanisms of vasodilation. In: PosteG, CrookeT, editors. Dopamine receptor agonist. New York: Plenum, 1983:259–288.
73.
LipptonHL, GruetterCA, IgnarroLJ, MeyerRL, KadowitzPJ. Vasodilator actions of several N-nitroso compounds. Can J Physiol Pharmacol1982;60:68–75.
74.
IgnarroLJ, BurkeTM, WoodKS, WolinMS, KadowitzPJ. Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J Pharmacol Exp Ther1983;228:682–690.
75.
RapoportRM, MuradF.Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res1983;52:352–357.
MacleodKM, NgDDW, HarrisKH, DiamondJ.Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to A-adrenoceptor stimulation. Mol Pharmacol1987;32:59–64.
78.
FeelischM, NoackE.Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron. Eur J Pharmacol1987;142(3):465–469.
79.
BigsonQH, RoughtonFJW. The kinetics of equilibria of the reactions of nitric oxide with sheep hemoglobin. J Physiol (Lond)1957;136:507–526.
80.
OdaH, KusumotoS, NakajimiaT.Nitrosylhemoglobin formation in the blood of animals exposed to nitric oxide. Arch Environ Health1975;30:453–465.
81.
ChiodiH, MohlerJG. Effects of exposure of blood hemoglobin to nitric oxide. Environ Res1985;37:355–363.
82.
IgnarroLJ. Biological actions and properties of endothelium derived nitric oxide formed and released from artery and vein. Circ Res1989;65:1–21.
83.
BorlandCD, HigenbottamTW. A simultaneous single breath measurement of pulmonary diffusing capacity with nitric oxide and carbon monoxide. Eur Respir J1989;2(1):56–63.
84.
DoyleMP, HoekstraJW. Oxidation of nitrogen oxides by bound dioxygen in haemoproteins. J Inorg Biochem1981;14:351–358.
85.
BorlandCDR, HarmesK, CracknellN, MackD, HigenbottamTW. Methaemoglobin levels in smokers and nonsmokers. Arch Environ Health1985;40:330–333.
86.
NormanV, KeithCH. Nitrogen oxides in tobacco smoke. Nature1965;205:915–916.
87.
RossaintR, FalkeKJ, KeitelM, LopezF, PisonU, SlamaK, . Inhaled nitric oxide in contrast to infused prostacyclin selectively reduces pulmonary hypertension and improves gas exchange in severe ARDS (abstract). Am Rev Respir Dis1992;145(4):A185.
88.
FalkeKJ, RossaintR, KeitelM, . Successful treatment of severe adult respiratory distress syndrome with nitric oxide: the first three patients. Second International Meeting on the Biology of Nitric Oxide. London, October, 1991.
89.
BlomqvistH, FrostellC, HedenstiernaG, ZapolWM. Inhaled nitric oxide (NO): a selective pulmonary vasodilator reversing human hypoxic pulmonary vasoconstriction (HPV) (abstract). Circulation1991;84:A361.
90.
American Thoracic Society, American Lung Association. International Conference. Final Program. Miami Beach: ATS/ALA, 1992.
91.
Pepke-ZabaJ, HigenbottamTW, Dinh-XuanAT, StoneD, WallworkJ.Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet1991;338:1173–1174.
92.
BigatelloLM, HurfordWE, KacmarekRM, RobertsJDJr, ZapolWM. Inhaled nitric oxide is a selective pulmonary vasodilator in septic patients with severe ARDS (abstract). Am Rev Respir Dis1992;145(4):A185.
93.
MoinardJ, PilletO, CastaingY, GuenardH.Inhaled nitric oxide: effects on pulmonary circulation and gas exchange in man (abstract). Am Rev Respir Dis1992;145(4):A207.
94.
DevlinR, HorstmanD, BeckerS, GerrityT, MaddenM, KorenH.Inflammatory response in humans exposed to 2.0 ppm NO2 (abstract). Am Rev Respir Dis1990;145(4):A456.
95.
GastonB, DrazenJM, JansenA, SugarbakerDA, LoscalzoJ, StamlerJS. Relaxation of human airways in-vitro by S-nitrosothiols (abstract). Am Rev Respir Dis1992;145(4):A383.
96.
Clutton-BrockJ.Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia. Br J Anaesth1967;39:388–392.
97.
AustinAT. The chemistry of the higher oxides of nitrogen as related to the manufacture, storage and administration of nitrous oxide. Br J Anaesth1967;39:345–350.
98.
GreenbaumR, BayJ, HargreavesMD, KainML, KelmanGR, NunnJF, . Effects of higher oxides of nitrogen on the anesthetized dog. Br J Anaesth1967;39:393–404.
99.
SackheimGI, LehmanDD, editors. Chemistry for the health sciences. New York: MacMillan, 1990:130–133.
100.
BrownRF, CliffordWE, MarrsTC, CoxRA. The histopathology of rat lung following short term exposures to mixed oxides of nitrogen (NOx). Br J Exp Pathol1983;64(6):579–593.
101.
SametJM, UtellMJ. The risk of nitrogen dioxide: what have we learned from epidemiological and clinical studies?Toxicol Indus Health1990;6(20):247–262.
102.
StavertDM, LehnertBE. Nitrogen oxide and nitrogen dioxide as inducers of acute pulmonary injury when inhaled at relatively high concentrations for brief periods. Inhal Toxicol1990;2:53–57.
103.
MMWR August 26, 1988, Vol 37, NO S-7(21).
104.
ClyneMAA, ThrushBA, WayneRP. Trans Faraday Soc1964;60:359.
105.
SeitzWR, NearyMP. Chemiluminescence and bioluminescence. Contemp Topics Anal Clin Chem1977;1:49–125.
106.
KrickaLJ, CarterTJN, editors. Clinical and biochemical luminescence. London: Marcel-Dekker, 1982:135–136.
107.
FontijnA, SabadellAJ, RoncoRJ. Homogeneous chemiluminescent measurement of nitric oxide with ozone. Anal Chem1970;42(6):574–579.
108.
PaiGT, PayneWJ, LeGallJ.Use of a chemiluminescence detector for quantitation of nitric oxide produced in assays of denitrifying enzymes. Anal Biochem1987;166:150–157.
109.
KacmarekRM. Respiratory care practitioner: carpe diem!Respir Care1992;37(3):264–269.